We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Microbiome Composition Altered in Fibromyalgia Patients

By LabMedica International staff writers
Posted on 11 Jul 2019
Print article
Image: Research shows fibromyalgia patients may have a distinct composition of gut microbiome species (Photo courtesy of Christopher Bergland).
Image: Research shows fibromyalgia patients may have a distinct composition of gut microbiome species (Photo courtesy of Christopher Bergland).
Fibromyalgia (FM) is a prevalent syndrome, characterized by chronic widespread pain, fatigue and impaired sleep, that is challenging to diagnose and difficult to treat. FM is a long-term condition that affects 2% to 4% of the USA population, which equates to about 6 to 12 million people.

The gut microbiome is a vast and complex ecosystem of bacteria, yeasts, viruses, fungi, and other microorganisms that inhabit the digestive tract. These microorganisms are constantly exchanging signals with the cells of their host. Numerous studies have revealed that the interaction between the gut microbiome and the body plays an important role in health and disease.

A multidisciplinary team led by McGill University Health Centre (Montreal, QC, Canada) enrolled 156 female Montreal residents who took part in the study, 77 had fibromyalgia, while the remaining 79 healthy individuals acted as controls. Some of the participants in the control group were the siblings, offspring, or parents of those with fibromyalgia or shared their living space. All participants gave samples of stool, urine, and saliva. They also underwent interviews. The scientists analyzed data from tests on the samples and from the interviews. They compared the results for the participants with fibromyalgia with those of their healthy counterparts.

The microbiomes of 77 women with FM and that of 79 control participants were compared using 16S rRNA gene amplification and whole genome sequencing. When comparing FM patients to unrelated controls using differential abundance analysis, significant differences were revealed in several bacterial taxa. Variance in the composition of the microbiomes was explained by FM-related variables more than by any other innate or environmental variable and correlated with clinical indices of FM. In line with observed alteration in butyrate metabolizing species, targeted serum metabolite analysis verified differences in the serum levels of butyrate and propionate in FM patients. To analyze the microbiomes in the stool samples, the team used machine learning and was able to identify which participants had fibromyalgia with an accuracy of 87.8%.

The team concluded that they observed a quantitative association between the abundance of several species of bacteria and the severity of fibromyalgia-related symptoms, including pain intensity, pain distribution, fatigue, sleep disturbances, and cognitive symptoms. They add that the abundance of the species of bacteria also correlated selectively with disease-related symptoms, but not with disease-independent variables. The article was published in the June 2019 issue of the journal Pain.

Related Links:
McGill University Health Centre

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.